Cite
HARVARD Citation
Howarth, P. et al. (2020). Eosinophil‐derived neurotoxin and clinical outcomes with mepolizumab in severe eosinophilic asthma. Allergy. 75 (8), pp. 2085-2088. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Howarth, P. et al. (2020). Eosinophil‐derived neurotoxin and clinical outcomes with mepolizumab in severe eosinophilic asthma. Allergy. 75 (8), pp. 2085-2088. [Online].